Patents by Inventor Kevin Charles Kain

Kevin Charles Kain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETECTING PATHOGENS USING MICROBEADS CONJUGATED TO BIORECOGNITION MOLECULES
    Publication number: 20160299137
    Abstract: A method and system are provided for the simultaneous detection and identification of multiple pathogens in a patient sample. The sample is combined with microbeads, which have been injected with quantum dots or fluorescent dye and conjugated to pathogen-specific biorecognition molecules, such as antibodies and oligonucleotides. Treatment options may be determined based on the identities of the pathogens detected in the sample.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 13, 2016
    Inventors: Michael Mordinson GREENBERG, Kevin Charles KAIN, Warren Che Wor CHAN
  • S1P RECEPTOR AGONISTS FOR THE TREATMENT OF CEREBRAL MALARIA
    Publication number: 20100112037
    Abstract: Methods and compositions for treating, managing, and/or preventing cerebral malaria are disclosed.
    Type: Application
    Filed: October 29, 2009
    Publication date: May 6, 2010
    Inventors: Max Bachrach, Constance Ann Marjory Finney, Kevin Charles Kain, Tamas Oravecz
  • S1P LYASE INHIBITORS FOR THE TREATMENT OF CEREBRAL MALARIA
    Publication number: 20100113530
    Abstract: Methods and compositions for treating, managing, and/or preventing cerebral malaria are disclosed.
    Type: Application
    Filed: October 29, 2009
    Publication date: May 6, 2010
    Inventors: Philip Manton Brown, Constance Ann Marjory Finney, Kevin Charles Kain, Tamas Oravecz, Stephen Chris Pappas
  • METHOD FOR DETECTING PATHOGENS USING MICROBEADS CONJUGATED TO BIORECOGNITION MOLECULES
    Publication number: 20100021937
    Abstract: A method and system are provided for the simultaneous detection and identification of multiple pathogens in a patient sample. The sample is combined with microbeads, which have been injected with quantum dots or fluorescent dye and conjugated to pathogen-specific biorecognition molecules, such as antibodies and oligonucleotides. Treatment options may be determined based on the identities of the pathogens detected in the sample.
    Type: Application
    Filed: February 13, 2007
    Publication date: January 28, 2010
    Applicant: FIO CORPORATION
    Inventors: Michael Mordinson Greenberg, Kevin Charles Kain, Warren Che Wor Chan